Atai Life Sciences
Tracked across 5 events · 73 articles · First seen Apr 18, 2026 · Last active Sep 11, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Business
Impact: Atai Life Sciences received a Silver Award in Ovid Health's 2026 Patient Participant Index for its collaboration with Psychedelic Participant Advocacy Network, enhancing its reputation in patient-informed research and potentially boosting investor confidence.
Apr 27, 2026 · 7 articles
Business
Impact: Atai Life Sciences is the target, receiving a 26% premium on its stock price. The acquisition provides access to Lilly's resources to accelerate development of its psychedelic therapies, particularly BPL-003 for treatment-resistant depression.
Jul 16, 2026 · 25 articles
Business
Eli Lilly and Company announced on September 11, 2026 the successful completion of its acquisition of Atai Life Sciences, a clinical-stage biopharmaceutical company developing rapid-acting neuroplastogens for mental health conditions. AtaiBeckley's lead investigational program, BPL-003,…
Impact: AtaiBeckley is the acquired clinical-stage biopharmaceutical company whose shareholders approved the transaction. Its lead program BPL-003 for treatment-resistant depression now advances under Lilly's ownership, providing resources for further clinical development.
Sep 11, 2026 · 6 articles
Regulatory
Impact: Atai Life Sciences is a company studying MDMA and other psychedelic compounds, benefiting from investments from figures like Peter Thiel as the regulatory environment shifts.
Apr 18, 2026 · 29 articles
Business
Impact: Acquired by Lilly; part of pipeline investment strategy.
Aug 23, 2026 · 6 articles
95
Eli Lilly and Company completed acquisition Atai Life SciencesLilly completes...
60
Atai Life Sciences approved acquisition Eli Lilly and CompanyLilly completes...
ERGEN INTELLIGENCE
Track Atai Life Sciences live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard